MicroVention today announced that the first U.S. clinical case of its flow diverter Fred X device was performed at Thomas Jefferson University Hospital in Philadelphia.
Aliso Viejo, California-based MicroVention received premarket approval for the Fred X device in September. It uses a self-expanding braided nitinol mesh to redirect blood flow and promote aneurysm occlusion. The added X technology reduces the thrombogenicity of the device material and enhances blood vessel healing.
Get the full story on our sister site, Medical Tubing + Extrusion.